Cargando…
Impact of smoking on dendritic cell phenotypes in the airway lumen of patients with COPD
BACKGROUND: Myeloid dendritic cells (DCs) are increased in the airway wall of patients with chronic obstructive pulmonary disease (COPD), and postulated to play a crucial role in COPD. However, DC phenotypes in COPD are poorly understood. METHODS: Function-associated surface molecules on bronchoalve...
Autores principales: | Stoll, Paul, Heinz, Ann-Sophie, Bratke, Kai, Bier, Andrea, Garbe, Katharina, Kuepper, Michael, Virchow, J Christian, Lommatzsch, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021430/ https://www.ncbi.nlm.nih.gov/pubmed/24742278 http://dx.doi.org/10.1186/1465-9921-15-48 |
Ejemplares similares
-
Fluticasone impact on airway dendritic cells in smokers: a randomized controlled trial
por: Lommatzsch, Marek, et al.
Publicado: (2013) -
Imbalance of dendritic cell co-stimulation in COPD
por: Stoll, Paul, et al.
Publicado: (2015) -
Stage-dependent association of BDNF and TGF-β(1) with lung function in stable COPD
por: Stoll, Paul, et al.
Publicado: (2012) -
Adverse effects of salmeterol in asthma: a neuronal perspective
por: Lommatzsch, M, et al.
Publicado: (2009) -
COVID‐19 in a patient with severe asthma treated with Omalizumab
por: Lommatzsch, Marek, et al.
Publicado: (2020)